Should I buy or sell LENSAR stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for LENSAR in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" LNSR shares. View LNSR analyst ratings or view top-rated stocks .

What is LENSAR's stock price target for 2024?

1 equities research analysts have issued twelve-month price targets for LENSAR's shares. Their LNSR share price targets range from $8.00 to $8.00. On average, they expect the company's stock price to reach $8.00 in the next year. This suggests a possible upside of 154.8% from the stock's current price. View analysts price targets for LNSR or view top-rated stocks among Wall Street analysts .

How have LNSR shares performed in 2024?

LENSAR's stock was trading at $3.51 at the beginning of the year. Since then, LNSR shares have decreased by 10.5% and is now trading at $3.14. View the best growth stocks for 2024 here .

Are investors shorting LENSAR?

LENSAR saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 77,300 shares, an increase of 85.8% from the March 15th total of 41,600 shares. Based on an average daily volume of 43,700 shares, the days-to-cover ratio is currently 1.8 days. Approximately 0.8% of the company's shares are short sold. View LENSAR's Short Interest .

When is LENSAR's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our LNSR earnings forecast .

How were LENSAR's earnings last quarter?

LENSAR, Inc. (NASDAQ:LNSR) posted its earnings results on Monday, March, 4th. The company reported ($0.22) earnings per share for the quarter, hitting the consensus estimate of ($0.22). The firm had revenue of $12.11 million for the quarter. LENSAR had a negative trailing twelve-month return on equity of 40.53% and a negative net margin of 34.11%.

How do I buy shares of LENSAR?

Shares of LNSR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:LNSR

LENSAR (LNSR) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free LNSR Stock Alerts

$3.14

+0.08 (+2.61%)

(As of 04/18/2024 ET)

Compare

Today's Range: $3.00
▼
$3.39
50-Day Range: $3.02
▼
$5.00
52-Week Range: $1.80
▼
$5.30

Volume: 38,851 shs
Average Volume: 41,150 shs
Market Capitalization: $35.80 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $8.00

Get LENSAR alerts:

LENSAR MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 154.8% Upside
$8.00 Price Target
Short Interest: Healthy
0.83% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.86 out of 5 stars

Medical Sector

592nd out of 918 stocks

Surgical & Medical Instruments Industry

60th out of 91 stocks

3.5

Analyst's Opinion

Consensus Rating
LENSAR has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
LENSAR has only been the subject of 1 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
0.83% of the float of LENSAR has been sold short.
Short Interest Ratio / Days to Cover
LENSAR has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in LENSAR has recently increased by 85.82%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
LENSAR does not currently pay a dividend.
Dividend Growth
LENSAR does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for LNSR.

N/A

News and Social Media Coverage

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, LENSAR insiders have not sold or bought any company stock.
Percentage Held by Insiders
38.52% of the stock of LENSAR is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
40.15% of the stock of LENSAR is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.0

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of LENSAR is -1.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of LENSAR is -1.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
LENSAR has a P/B Ratio of 1.06. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Crypto Swap Profits

Claim Your Complimentary Bitcoin Reward

Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Secure Your Spot Now

About LENSAR Stock (NASDAQ:LNSR)

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

LNSR Stock Price History

30 days | 90 days | 365 days | Advanced Chart

LNSR Stock News Headlines

April 1, 2024 | businesswire.com

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 7, 2024 | finance.yahoo.com

LENSAR, Inc. (NASDAQ:LNSR) Just Reported Earnings, And Analysts Cut Their Target Price

April 19, 2024 | Weiss Ratings (Ad)

The only accurate crypto trading system I know …

Juan Villaverde is no ordinary crypto trader. His proprietary timing algorithm has led him to rack up a series of gains of 477%, 333% and 153% on Bitcoin … It pointed the way to Cardano, at just 4 cents …Helping investors make 29 times their money.

March 5, 2024 | markets.businessinsider.com

Analysts’ Top Healthcare Picks: 89bio (ETNB), UnitedHealth (UNH)

March 5, 2024 | finance.yahoo.com

LENSAR, Inc. (NASDAQ:LNSR) Q4 2023 Earnings Call Transcript

March 5, 2024 | finance.yahoo.com

LENSAR Full Year 2023 Earnings: EPS Beats Expectations

March 4, 2024 | finance.yahoo.com

LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

March 1, 2024 | businesswire.com

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 19, 2024 | Weiss Ratings (Ad)

The only accurate crypto trading system I know …

March 1, 2024 | businesswire.com

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 1, 2024 | msn.com

LENSAR Q4 2023 Earnings Preview

February 28, 2024 | markets.businessinsider.com

Navigating 6 Analyst Ratings For Viridian Therapeutics

February 26, 2024 | businesswire.com

LENSAR to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 4, 2024

February 26, 2024 | businesswire.com

LENSAR to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 4, 2024

February 22, 2024 | benzinga.com

LENSAR Stock (NASDAQ:LNSR), Short Interest Report

February 7, 2024 | msn.com

LENSAR Board Approves Executive Bonuses for 2023 Performance

January 25, 2024 | finance.yahoo.com

LENSAR Decline Means Insider Profits Down To US$42k

November 12, 2023 | finance.yahoo.com

LENSAR, Inc. (NASDAQ:LNSR) Q3 2023 Earnings Call Transcript

November 9, 2023 | finance.yahoo.com

LENSAR Inc (LNSR) Reports 26% Revenue Growth in Q3 2023 Amid Expanding ALLY System Installations

November 9, 2023 | finance.yahoo.com

LENSAR Reports Third Quarter 2023 Results and Provides Business Update

November 8, 2023 | benzinga.com

LENSAR's Earnings Outlook

November 2, 2023 | finance.yahoo.com

LENSAR to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

October 11, 2023 | uk.sports.yahoo.com

German tattoo artist taken hostage by Hamas ‘still alive’ says her mother

October 11, 2023 | finance.yahoo.com

A Piece Of The Puzzle Missing From LENSAR, Inc.'s (NASDAQ:LNSR) Share Price

September 14, 2023 | finance.yahoo.com

Will LENSAR (NASDAQ:LNSR) Spend Its Cash Wisely?

August 18, 2023 | finance.yahoo.com

Several Insiders Invested In LENSAR Flagging Positive News

August 9, 2023 | finance.yahoo.com

LENSAR Reports Second Quarter 2023 Results and Provides Business Update

See More Headlines

Receive LNSR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LENSAR and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/04/2024
Today: 4/18/2024
Next Earnings (Estimated): 5/20/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: NASDAQ:LNSR
CUSIP: N/A
CIK: 1320350
Web: www.lensar.com
Phone: 888-536-7271
Fax: N/A
Employees: 130
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $8.00
High Stock Price Target: $8.00
Low Stock Price Target: $8.00
Potential Upside/Downside: +154.8%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.79)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-14,380,000.00
Net Margins: -34.11%
Pretax Margin: -34.11%
Return on Equity: -40.53%
Return on Assets: -21.83%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 3.99
Quick Ratio: 2.64

Sales & Book Value

Annual Sales: $42.16 million
Price / Sales: 0.85
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.97 per share
Price / Book: 1.06

Miscellaneous

Outstanding Shares: 11,400,000
Free Float: 7,006,000
Market Cap: $35.80 million
Optionable: Optionable
Beta: 0.47

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Mr. Thomas R. Staab II (Age 56)
CPA, CFO & Secretary
Comp: $612.55k
Mr. Alan B. Connaughton (Age 52)
Chief Operating Officer
Comp: $650.62k
Ms. Kendra W. Wong (Age 44)
Principal Accounting Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

LNSR Stock Analysis - Frequently Asked Questions

Should I buy or sell LENSAR stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for LENSAR in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" LNSR shares.
View LNSR analyst ratings or view top-rated stocks.
What is LENSAR's stock price target for 2024?: 1 equities research analysts have issued twelve-month price targets for LENSAR's shares. Their LNSR share price targets range from $8.00 to $8.00. On average, they expect the company's stock price to reach $8.00 in the next year. This suggests a possible upside of 154.8% from the stock's current price.
View analysts price targets for LNSR or view top-rated stocks among Wall Street analysts.
How have LNSR shares performed in 2024?: LENSAR's stock was trading at $3.51 at the beginning of the year. Since then, LNSR shares have decreased by 10.5% and is now trading at $3.14.
View the best growth stocks for 2024 here.
Are investors shorting LENSAR?: LENSAR saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 77,300 shares, an increase of 85.8% from the March 15th total of 41,600 shares. Based on an average daily volume of 43,700 shares, the days-to-cover ratio is currently 1.8 days. Approximately 0.8% of the company's shares are short sold.
View LENSAR's Short Interest.

When is LENSAR's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our LNSR earnings forecast.
How were LENSAR's earnings last quarter?: LENSAR, Inc. (NASDAQ:LNSR) posted its earnings results on Monday, March, 4th. The company reported ($0.22) earnings per share for the quarter, hitting the consensus estimate of ($0.22). The firm had revenue of $12.11 million for the quarter. LENSAR had a negative trailing twelve-month return on equity of 40.53% and a negative net margin of 34.11%.
How do I buy shares of LENSAR?: Shares of LNSR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:LNSR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

LENSAR (LNSR) Stock Price, News & Analysis

LENSAR MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

Company Ownership

Earnings and Valuation

About LENSAR Stock (NASDAQ:LNSR)

LNSR Stock Price History

LNSR Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

LNSR Stock Analysis - Frequently Asked Questions

Overall MarketRank^™